Lv41
708 积分 2024-11-04 加入
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
4小时前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
8小时前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
8小时前
已关闭
Selectively N‐Methylated Soluble IAPP Mimics as Potent IAPP Receptor Agonists and Nanomolar Inhibitors of Cytotoxic Self‐Assembly of Both IAPP and Aβ40
14天前
已完结
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents
27天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
New Approaches to Chronic Hepatitis B
1个月前
已完结
Hepatitis B and D virus entry
1个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
1个月前
已完结
Trends in the drug target landscape for autoimmune diseases
2个月前
已完结
皖公网安备34019202002308
